The results showed that the expression level of TTC36 from malignant tissues, whether they are primary tumor (P = 0.031), liver metastasis (P = 0.025) or tumor lymph node invasion site (P = 0.043), are less than that of corresponding normal tissues (Fig. 1D), these results provide evidence that decreased TTC36 expression accompanied by GC progression and infiltration of surrounding tissues. Here, TTC36 is linked to neoplasm.